Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Feb 9, 2011

Premium

Response Genetics announced that Christine Meda is the firm's new president. Kathleen Danenberg, Response Genetics' previous president, will remain with the firm as its CEO.

Before coming to Response Genetics, Meda was president and CEO of molecular diagnostics company Arcxis Biotechnologies, as well as president and chief operating officer for the cancer diagnostics firm Diamics. She also founded and is president of RxDxLink, a consulting firm focused on early-stage and small biotechnology companies.


NanoString Technologies recently announced the appointment of J. Wayne Cowens as its chief medical officer. Cowens will be responsible for developing NanoString's molecular diagnostics pipeline in oncology.

Before joining NanoString, Cowens held various leadership positions at Genomic Health, including VP of clinical oncology.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.